European small and mid caps-Stock picks Q4 2007-Q1 2008 - Fourlis
European small and mid caps-Stock picks Q4 2007-Q1 2008 - Fourlis
European small and mid caps-Stock picks Q4 2007-Q1 2008 - Fourlis
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Mid cap<br />
<strong>European</strong> <strong>small</strong> <strong>and</strong> <strong>mid</strong> <strong>caps</strong><br />
17 October <strong>2007</strong><br />
abc<br />
Spectris<br />
Market-leading niche supplier of testing <strong>and</strong> inspection equipment<br />
Robust dem<strong>and</strong> backdrop <strong>and</strong> restructuring should drive strong<br />
near-term EPS growth<br />
Rising CFROI <strong>and</strong> low cost of capital lead to 1,010p target price,<br />
reiterate Overweight rating<br />
Investment summary<br />
Spectris is a niche producer of testing <strong>and</strong><br />
inspection equipment, serving a broad range of<br />
end-markets <strong>and</strong> selling directly to a largely bluechip<br />
customer base. The group typically invests<br />
around 7% of sales in R&D <strong>and</strong> develops whollyowned<br />
intellectual property in order to<br />
differentiate itself on product excellence rather<br />
than price. Although the aftermarket represents a<br />
modest proportion of total sales (c25%), unlike<br />
many of its competitors Spectris is reluctant to<br />
sacrifice product margin in search of more stable<br />
service revenues.<br />
Market backdrop is especially robust<br />
The group is currently benefiting from a strong<br />
industrial backdrop in emerging economies,<br />
combined with buoyant market conditions in<br />
Continental Europe. Together, these areas account<br />
for nearly two-thirds of group sales. Medium-term<br />
dem<strong>and</strong> is underpinned by positive drivers for<br />
testing <strong>and</strong> inspection, supported by environmental<br />
regulation on emissions, noise, waste, <strong>and</strong> health<br />
<strong>and</strong> safety, for which trends are increasingly<br />
migrating towards developing markets.<br />
Furthermore, despite the group’s market exposure<br />
being fairly diverse, we estimate that process<br />
industries account for c50% of sales – this is an<br />
area where we forecast a 13% increase in capital<br />
investment over the next two years.<br />
Margins reaching respectable levels<br />
Historically, Spectris’ margins have been<br />
uninspiring, but management’s efforts have<br />
recently focused on enhancing profitability<br />
through recent restructuring initiatives <strong>and</strong><br />
disposals. As a result, we believe the group is now<br />
on course to meet <strong>mid</strong>-teens margin targets in FY<br />
<strong>2007</strong> (from 12.2% in FY 2006), despite<br />
substantial currency headwinds.<br />
Key facts ____________________Financial summary _____________________ ___________ Valuation summary ___________<br />
Analyst: Gary Murphy<br />
Year to Revenue EBITDA HSBC HSBC HSBC Yield HSBC EV/ EV/IC ROIC HSBC<br />
Tel: +44 20 7991 6749<br />
December (GBPm) (GBPm) net profit EPS EPS growth (%) PE EBITDA (x) (%) REP<br />
Email: gary.murphy@hsbcib.com<br />
(GBPm) (GBp) (%)<br />
(x) (x)<br />
(x)<br />
Current price (GBP) 9.08 12/2006a 642.6 66.5 54.6 0.44 22.5 1.9 20.7 11.8 3.4 18.4 1.2<br />
Target price (GBP) 10.1 12/<strong>2007</strong>e 656.1 98.8 66.8 0.55 25.1 2.2 16.6 10.3 3.2 20.1 1.6<br />
Mkt cap (GBPm) 1,088 12/<strong>2008</strong>e 687.5 101.0 71.4 0.62 12.2 2.4 14.8 9.3 3.3 21.1 1.7<br />
Bloomberg SXS LN 12/2009e 715.5 101.3 77.3 0.67 8.2 2.5 13.7 8.5 3.1 22.6 1.6<br />
Reuters<br />
SXS.L<br />
Source: company data, HSBC estimates<br />
64